Abstract
Purpose
Ovarian carcinoma (OC) is the most lethal female genital cancer. After a primary curative surgical approach followed by chemotherapy, a fraction of the patients recur with chemoresistant disease. Data indicate a favorable therapeutic effect of tumor-infiltrating neutrophils (TIN) in OC. Our aim was to investigate the prognostic role of CD66b expression, corresponding to neutrophilic infiltration for recurrence-free survival (RFS) and overall survival (OS) in patients with OC.
Methods
A collective of 47 primary serous ovarian carcinoma and their matching recurrences were processed and stained with CD66b using immunohistochemistry. Tumors from patients with RFS of more than 6 months were defined as chemosensitive. Statistical analysis of CD66b expression was performed to assess the clinical endpoints.
Results
High density of CD66b expressing neutrophils in primary carcinoma was associated with chemosensitivity (p = 0.014) and longer RFS (p = 0.001). Univariate analysis identified high density of CD66b expressing neutrophils as a predictor for favorable RFS (HR 0.41, 95% CI 0.22–0.76, p < 0.005). Residual disease > 2 cm (HR 3.67, 95% CI 1.62–8.31, p < 0.002) and higher number of chemotherapy cycles (HR 1.28, 95% CI 1.05–1.55, p < 0.013) were associated with worse RFS. Multivariate analysis showed that high density of CD66b expressing neutrophils (HR 0.22, 95% CI 0.10–0.48, p < 0.001) and residual disease > 2 cm (HR 3.69, 95% CI 1.43–9.53, p < 0.007) were independent predictors of RFS but had no impact on OS.
Conclusion
High CD66b neutrophil density in primary high-grade OC predicts good response to initial chemotherapy and longer recurrence-free survival independent of known risk factors.
Similar content being viewed by others
References
Abu-Shawer O, Abu-Shawer M, Hirmas N, Alhouri A, Massad A, Alsibai B et al (2019) Hematologic markers of distant metastases and poor prognosis in gynecological cancers. BMC Cancer 19(1):141
Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539–545
Barcellos-Hoff MH, Dix TA (1996) Redox-mediated activation of latent transforming growth factor-beta 1. Mol Endocrinol 10(9):1077–1083
Borregaard N (2010) Neutrophils, from marrow to microbes. Immunity 33(5):657–670
Bubendorf L, Nocito A, Moch H, Sauter G (2001) Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 195(1):72–79
Cadet J, Wagner JR (2013) DNA base damage by reactive oxygen species, oxidizing agents, and UV radiation. Cold Spring Harb Perspect Biol 5(2):a012559
Carus A, Ladekarl M, Hager H, Nedergaard BS, Donskov F (2013) Tumour-associated CD66b+ neutrophil count is an independent prognostic factor for recurrence in localised cervical cancer. Br J Cancer 108(10):2116–2122
Caruso RA, Bellocco R, Pagano M, Bertoli G, Rigoli L, Inferrera C (2002) Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy. Mod Pathol 15(8):831–837
Chen G, Zhu L, Yang Y, Long Y, Li X, Wang Y (2018) Prognostic role of neutrophil to lymphocyte ratio in ovarian cancer: a meta-analysis. Technol Cancer Res Treat 17:1533033818791500
Cho H, Hur HW, Kim SW, Kim SH, Kim JH, Kim YT et al (2009) Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother 58(1):15–23
Christie EL, Bowtell DDL (2018) Acquired chemotherapy resistance in ovarian cancer. Ann Oncol 28:813–815
Coburn SB, Bray F, Sherman ME, Trabert B (2017) International patterns and trends in ovarian cancer incidence, overall and by histologic subtype. Int J Cancer 140(11):2451–2460
Coffelt SB, Wellenstein MD, de Visser KE (2016) Neutrophils in cancer: neutral no more. Nat Rev Cancer 16(7):431–446
Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17(10):1195–1214
Cortez AJ, Tudrej P, Kujawa KA, Lisowska KM (2018) Advances in ovarian cancer therapy. Cancer Chemother Pharmacol 81(1):17–38
Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860–867
Deree J, Lall R, Melbostad H, Grant M, Hoyt DB, Coimbra R (2006) Neutrophil degranulation and the effects of phosphodiesterase inhibition. J Surg Res 133(1):22–28
Dijkgraaf EM, Heusinkveld M, Tummers B, Vogelpoel LT, Goedemans R, Jha V et al (2013) Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment. Cancer Res 73(8):2480–2492
Droeser RA, Guth U, Eppenberger-Castori S, Stadlmann S, Hirt C, Terracciano L et al (2013) High IL-17-positive tumor immune cell infiltration is indicative for chemosensitivity of ovarian carcinoma. J Cancer Res Clin Oncol 139(8):1295–1302
Droeser RA, Mechera R, Daster S, Weixler B, Kraljević M, Delko T et al (2016) MPO density in primary cancer biopsies of ovarian carcinoma enhances the indicative value of IL-17 for chemosensitivity. BMC Cancer 16:639
El Bairi K, Kandhro AH, Gouri A, Mahfoud W, Louanjli N, Saadani B et al (2017) Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer. Cell Oncol (Dordr) 40(2):105–118
Feng Z, Wen H, Bi R, Ju X, Chen X, Yang W et al (2016) Preoperative neutrophil-to-lymphocyte ratio as a predictive and prognostic factor for high-grade serous ovarian cancer. PLoS ONE 11(5):e0156101
Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L et al (2009) Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 16(3):183–194
Friedlander M, Trimble E, Tinker A, Alberts D, Avall-Lundqvist E, Brady M et al (2011) Clinical trials in recurrent ovarian cancer. Int J Gynecol Cancer 21(4):771–775
Galdiero MR, Bianchi P, Grizzi F, Di Caro G, Basso G, Ponzetta A et al (2016) Occurrence and significance of tumor-associated neutrophils in patients with colorectal cancer. Int J Cancer 139(2):446–456
Giese MA, Hind LE, Huttenlocher A (2019) Neutrophil plasticity in the tumor microenvironment. Blood 133(20):2159–2167
Granot Z, Henke E, Comen EA, King TA, Norton L, Benezra R (2011) Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell 20(3):300–314
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674
Ilie M, Hofman V, Ortholan C, Bonnetaud C, Coëlle C, Mouroux J et al (2012) Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer. Cancer 118(6):1726–1737
Jazaeri AA, Awtrey CS, Chandramouli GV, Chuang YE, Khan J, Sotiriou C et al (2005) Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers. Clin Cancer Res 11(17):6300–6310
Jensen HK, Donskov F, Marcussen N, Nordsmark M, Lundbeck F, von der Maase H (2009) Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J Clin Oncol 27(28):4709–4717
Krawisz JE, Sharon P, Stenson WF (1984) Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87(6):1344–1350
Kruger P, Saffarzadeh M, Weber AN, Rieber N, Radsak M, von Bernuth H et al (2015) Neutrophils: between host defence, immune modulation, and tissue injury. PLoS Pathog 11(3):e1004651
Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI (2004) Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J Immunol 172(2):989–999
Lakschevitz FS, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M (2016) Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res 342(2):200–209
Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C (2013) Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(Suppl 6):624–632
Li YW, Qiu SJ, Fan J, Zhou J, Gao Q, Xiao YS et al (2011) Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. J Hepatol 54(3):497–505
Lopez-Lago MA, Posner S, Thodima VJ, Molina AM, Motzer RJ, Chaganti RS (2013) Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression. Oncogene 32(14):1752–1760
Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23(11):549–555
Mantovani A, Cassatella MA, Costantini C, Jaillon S (2011) Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 11(8):519–531
Murdoch C, Muthana M, Coffelt SB, Lewis CE (2008) The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8(8):618–631
Nakamura K, Nagasaka T, Nishida T, Haruma T, Ogawa C, Kusumoto T et al (2016) Neutrophil to lymphocyte ratio in the pre-treatment phase of final-line chemotherapy predicts the outcome of patients with recurrent ovarian cancer. Oncol Lett 11(6):3975–3981
Pillay J, den Braber I, Vrisekoop N, Kwast LM, de Boer RJ, Borghans JA et al (2010) In vivo labeling with 2H2O reveals a human neutrophil lifespan of 54 days. Blood 116(4):625–627
Pölcher M, Braun M, Friedrichs N, Rudlowski C, Bercht E, Fimmers R et al (2010) Foxp3(+) cell infiltration and granzyme B(+)/Foxp3(+) cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma. Cancer Immunol Immunother 59(6):909–919
Richardson JJR, Hendrickse C, Gao-Smith F, Thickett DR (2017) Neutrophil extracellular trap production in patients with colorectal cancer in vitro. Int J Inflamm 2017:4915062
Sato S, Kigawa J, Minagawa Y, Okada M, Shimada M, Takahashi M et al (1999) Chemosensitivity and p53-dependent apoptosis in epithelial ovarian carcinoma. Cancer 86(7):1307–1313
Sauter G, Simon R, Hillan K (2003) Tissue microarrays in drug discovery. Nat Rev Drug Discov 2(12):962–972
Schroder AK, Uciechowski P, Fleischer D, Rink L (2006) Crosslinking of CD66B on peripheral blood neutrophils mediates the release of interleukin-8 from intracellular storage. Hum Immunol 67(9):676–682
Shaul ME, Fridlender ZG (2017) Neutrophils as active regulators of the immune system in the tumor microenvironment. J Leukoc Biol 102(2):343–349
Shen M, Hu P, Donskov F, Wang G, Liu Q, Du J (2014) Tumor-associated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysis. PLoS ONE 9(6):e98259
Singer G, Kurman RJ, Chang HW, Cho SK, Shih IM (2002) Diverse tumorigenic pathways in ovarian serous carcinoma. Am J Pathol 160(4):1223–1228
Singer G, Oldt R 3rd, Cohen Y, Wang BG, Sidransky D, Kurman RJ et al (2003) Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst 95(6):484–486
Sionov RV, Fridlender ZG, Granot Z (2015) The multifaceted roles neutrophils play in the tumor microenvironment. Cancer Microenviron 8(3):125–158
Sounni NE, Noel A (2013) Targeting the tumor microenvironment for cancer therapy. Clin Chem 59(1):85–93
Stadlmann S, Gueth U, Reiser U, Diener PA, Zeimet AG, Wight E et al (2006) Epithelial growth factor receptor status in primary and recurrent ovarian cancer. Mod Pathol 19(4):607–610
Tabaries S, Ouellet V, Hsu BE, Annis MG, Rose AA, Meunier L et al (2015) Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases. Breast Cancer Res 17:45
Templeton AJ, McNamara MG, Seruga B, Vera-Badillo FE, Aneja P, Ocaña A et al (2014) Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 106(6):124
Tillack K, Breiden P, Martin R, Sospedra M (2012) T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses. J Immunol 188(7):3150–3159
Trellakis S, Bruderek K, Dumitru CA, Gholaman H, Gu X, Bankfalvi A et al (2011) Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer 129(9):2183–2193
Vanhamme L, Zouaoui Boudjeltia K, Van Antwerpen P, Delporte C (2018) The other myeloperoxidase: emerging functions. Arch Biochem Biophys 649:1–14
Wang J, Bo X, Suo T, Liu H, Ni X, Shen S et al (2018) Tumor-infiltrating neutrophils predict prognosis and adjuvant chemotherapeutic benefit in patients with biliary cancer. Cancer Sci 109(7):2266–2274
Winterbourn CC, Kettle AJ, Hampton MB (2016) Reactive oxygen species and neutrophil function. Annu Rev Biochem 85:765–792
Wislez M, Rabbe N, Marchal J, Milleron B, Crestani B, Mayaud C et al (2003) Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death. Cancer Res 63(6):1405–1412
Wu T, Dai Y (2017) Tumor microenvironment and therapeutic response. Cancer Lett 387:61–68
Yoon J, Terada A, Kita H (2007) CD66b regulates adhesion and activation of human eosinophils. J Immunol 179(12):8454–8462
Zahreddine H, Borden KL (2013) Mechanisms and insights into drug resistance in cancer. Front Pharmacol 4:28
Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G et al (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348(3):203–213
Zhang H, Liu H, Shen Z, Lin C, Wang X, Qin J et al (2018) Tumor-infiltrating neutrophils is prognostic and predictive for postoperative adjuvant chemotherapy benefit in patients with gastric cancer. Ann Surg 267(2):311–318
Zhao L, Xu S, Fjaertoft G, Pauksen K, Håkansson L, Venge P (2004) An enzyme-linked immunosorbent assay for human carcinoembryonic antigen-related cell adhesion molecule 8, a biological marker of granulocyte activities in vivo. J Immunol Methods 293(1–2):207–214
Zhao Z, Zhao X, Lu J, Xue J, Liu P, Mao H (2018) Prognostic roles of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in ovarian cancer: a meta-analysis of retrospective studies. Arch Gynecol Obstet 297(4):849–857
Acknowledgements
All authors declare that there are no sources of support or sponsorship in relation to this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors state that they have no conflicts of interest in relation to this manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Posabella, A., Köhn, P., Lalos, A. et al. High density of CD66b in primary high-grade ovarian cancer independently predicts response to chemotherapy. J Cancer Res Clin Oncol 146, 127–136 (2020). https://doi.org/10.1007/s00432-019-03108-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-019-03108-6